Get all the updates for this publication
Obesity negatively impacts maintenance of antibody response to COVID-19 vaccines
Severe obesity accelerates the decline of neutralizing antibodies to COVID-19 vaccines contributing to increased risk of hospitalization from breakthrough SARS-CoV-2 infections.1 These findings have repercussion on the vaccination policy for SARS-CoV-2 variants and other infectious diseases like influenza in obese population.
Journal | Cell Reports Medicine |
---|---|
Publisher | CELL PRESS |
ISSN | 2666-3791 |
Open Access | No |